BlackRock Institutional Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

BlackRock Institutional Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$119M	Buy	1,090,688 +27,850	+3%	+$3.1M	0.02%	818
2016 Q3	$129M	Buy	1,062,838 +1,159	+0.1%	+$156K	0.02%	746
2016 Q2	$150M	Sell	1,061,679 -411,447	-28%	-$60.7M	0.02%	661
2016 Q1	$192M	Sell	1,473,126 -17,689	-1%	-$2.2M	0.03%	551
2015 Q4	$210M	Buy	1,490,815 +16,178	+1%	+$2.24M	0.03%	512
2015 Q3	$196M	Buy	1,474,637 +23,662	+2%	+$4.07M	0.03%	530
2015 Q2	$255M	Buy	+1,450,975	New	+$261M	0.04%	444
2015 Q1	–	Sell	-1,476,998	Closed	-$242M	–	3868
2014 Q4	$242M	Buy	1,476,998 +52,624	+4%	+$8.73M	0.04%	459
2014 Q3	$229M	Buy	1,424,374 +74,531	+6%	+$11.5M	0.04%	458
2014 Q2	$198M	Buy	1,349,843 +13,324	+1%	+$1.85M	0.03%	530
2014 Q1	$185M	Buy	1,336,519 +74,451	+6%	+$11.2M	0.03%	554
2013 Q4	$160M	Buy	1,262,068 +40,194	+3%	+$4.16M	0.03%	600
2013 Q3	$112M	Buy	1,221,874 +15,174	+1%	+$1.22M	0.02%	724
2013 Q2	$82.9M	Buy	+1,206,700	New	+$73.8M	0.02%	839

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock Institutional Trust's JAZZ Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q4 2016, buying an estimated $3.1M and bringing the position to 1,090,688 shares worth $119M. The position accounts for 0.02% of the portfolio, ranked #818.

BlackRock Institutional Trust first reported a position in JAZZ in Q2 2013 and has held it in 14 quarters since. The position peaked at $255M in Q2 2015. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

BlackRock Institutional Trust held 1,090,688 shares of Jazz Pharmaceuticals worth $119M as of Q4 2016.
BlackRock Institutional Trust bought 27,850 Jazz Pharmaceuticals shares in Q4 2016, an estimated $3.1M.
Jazz Pharmaceuticals made up 0.02% of BlackRock Institutional Trust's portfolio in Q4 2016, its #818 holding.
BlackRock Institutional Trust first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
BlackRock Institutional Trust's Jazz Pharmaceuticals position peaked at $255M in Q2 2015.
295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.